Oragenics Inc

Research Oragenics Inc (OGEN) on Bullrun: market cap USD 2.58M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOGEN
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.58M
• Financial periodFY2025
• Net income-USD 984.25M

Valuation Snapshot

latest market cap is USD 2.58M.

About Oragenics Inc

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.

Frequently asked questions

What is Oragenics Inc's market cap?

Oragenics Inc's market capitalization is USD 2.58M.

What does Oragenics Inc do?

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States.